close icon-linkedin icon-twitter icon-facebook icon-mail icon-google-plus icon-search icon-phone icon-instagram
What are you looking for?
Evangelia Thanou

Evangelia Thanou

Trainee patent attorney
Embarking on my role as a trainee patent attorney at NLO in biotechnology and life sciences, I bring specialised knowledge acquired during my academic journey in neuroscience, proteomics, and mass spectrometry. My unique perspective, integrating hands-on research experience with legal insights, enables me to communicate effectively with clients and translate their innovations into protected assets.


  • Antibody
  • Biotechnology
  • Gene therapy
  • Pharma
  • Medicines
  • Oligonucleotide
  • Plants

I joined NLO in 2024, after completing a Ph.D. in neuroscience at the Vrije Universiteit in Amsterdam. During my Ph.D., I specialised in proteomics and mass spectrometry research for neurodegenerative diseases and neuroinflammation. I have extensive experience working with protein-protein interaction, post-translational modifications, exosomes, small drug mimetic molecules, and potential biomarkers. 

Driven by a passion for innovation and cutting-edge progress, I approach every client’s intellectual property journey with a positive mindset. I am dedicated to supporting clients comprehensively, from understanding their unique needs to safeguarding their inventions. 

Training & Education

  • Ph.D. in Neuroscience, Vrije Universiteit Amsterdam
  • MSc. in Molecular Biomedicine: Mechanisms of Disease, Molecular and Cellular therapies & Bioinnovation, National and Kapodistrian University of Athens
  • BSc. in Biology: Molecular Biology and Biotechnology, University of Crete


  • Thanou E, Koopmans F, Pita-Illobre D, Klaassen RV, Özer B, Charalampopoulos I, Smit AB, Li KW. Suspension TRAPping Filter (sTRAP) Sample Preparation for Quantitative Proteomics in the Low µg Input Range Using a Plasmid DNA Micro-Spin Column: Analysis of the Hippocampus from the 5xFAD Alzheimer's Disease Mouse Model. Cells. 2023 Apr 25;12(9):1242. doi: 10.3390/cells12091242. PMID: 37174641; PMCID: PMC10177283.
  • Yilmaz C, Rogdakis T, Latorrata A, Thanou E, Karadima E, Papadimitriou E, Siapi E, Li KW, Katsila T, Calogeropoulou T, Charalampopoulos I, Alexaki VI. ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses. Biomolecules. 2022 Mar 9;12(3):424. doi: 10.3390/biom12030424. PMID: 35327616; PMCID: PMC8946810.
  • Mateska I, Witt A, Hagag E, Sinha A, Yilmaz C, Thanou E, Sun N, Kolliniati O, Patschin M, Abdelmegeed H, Henneicke H, Kanczkowski W, Wielockx B, Tsatsanis C, Dahl A, Walch AK, Li KW, Peitzsch M, Chavakis T, Alexaki VI. Succinate mediates inflammation-induced adrenocortical dysfunction. Elife. 2023 Jul 14;12:e83064. doi: 10.7554/eLife.83064. PMID: 37449973; PMCID: PMC10374281.